Immunophotonics Announces Issuance of U.S. Patent Covering Lead Drug Candidate
ST. LOUIS and BERN, Switzerland, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Immunophotonics, Inc., a clinical-stage biopharmaceutical company focused on the...
News
Nuvectis Pharma In-Licenses Exclusive Worldwide Rights to a Novel SRC/YES1 Inhibitor (NXP900) from the University of Edinburgh, Scotland
•NXP900 is a SRC/YES1 Kinase Inhibitor with a Novel and Differentiated Mechanism of Action.FORT LEE, NJ , Sept. 14, 2021...
Wesana Health Commits Funding of $1.5 Million To Support MAPS’ Research Pipeline
MAPS to Investigate Viability of Research Pathway for MDMA-Assisted Therapy to Treat Traumatic Brain Injury Effort Positions MAPS, Sponsor of...
PharmaCielo Receives Confirmation of Colombian Phytotherapeutics GMP Certification
GMPi certification has been confirmed by INVIMA.The certification covers Phytotherapeutics manufactured with PharmaCielo´s extracts and proprietary cultivars.PharmaCielo’s Processing and Extraction Centre...
Beyond Air® to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
GARDEN CITY, N.Y., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical...
Progenity Announces Patent Granted by USPTO for its Preeclampsia Rule-Out Test
SAN DIEGO, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the...
Dante Labs Announces Expansion of its Finance Team with the Appointment of Andre Nel as Chief Financial Officer, Dalila Rahmani as Chief Accounting Officer, Laura D’Angelo as VP Investor Relations and Omar Elbakshish as Senior Director
CAMBRIDGE, United Kingdom, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomics and precision medicine, today...
AzurRx BioPharma CEO Issues Letter to Shareholders Regarding Recent Acquisition of First Wave Bio and Creation of First Wave BioPharma
BOCA RATON, Fla., Sept. 14, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX), (“First Wave BioPharma” or the “Company”), a...
Mindset Pharma Further Validates Lead Candidate, MSP-1014, as a Next Generation Psilocybin Analog through Drug Discrimination Assay
TORONTO, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"),...
Helius Medical Technologies, Inc. Appoints Paul Buckman to its Board of Directors
NEWTOWN, Pa., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company...
Matinas BioPharma Announces Webcast of Presentation at the H.C. Wainwright Global Investment Conference
BEDMINSTER, N.J., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), today announced that Jerome D....
Mount Sinai Initiates System-wide Scale-Up of Renalytix KidneyIntelX™ Enabled Health Care Model
Targeted testing run rate of 300 diabetic kidney disease patients per week in calendar Q4 2021NEW YORK and SALT LAKE...
Galera to Host Virtual Key Opinion Leader Event on Radiotherapy-Induced Severe Oral Mucositis (SOM) in Patients with Head and Neck Cancer
Event to be webcast on Thursday, September 23 at 11:00 a.m. ET Phase 3 ROMAN trial of avasopasem manganese, Galera’s...
Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.
LAKEWOOD, Colo., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“we”, “us”, “our”, “Mesa” or the “Company”), a...
COMPASS Pathways acquires IP portfolio of novel psychedelic compounds and prodrugs
COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in...
Acarix begins US expansion and appoints US President
Press releaseMalmö, Sweden, September 14, 2021 Acarix begins US expansion and appoints US President Acarix is announcing today that the...
Vanqua Bio Launches with $85 Million Series B Financing and a Mission to Vanquish Neurodegenerative Diseases
– Novel drug-development approach combines advanced insights into critical neuronal cell pathways with cutting-edge assays to enable next-generation therapies –...
Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-07 for the Acute Treatment of Migraine
NEW YORK, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for...
Jushi Holdings Inc. Announces Upcoming Launch of Flower Brands, The Bank and Sèche in Virginia as Commonwealth’s Flower Sales Begin
Company Introduces New Cannabis Delivery Pilot Program Jushi Holdings Inc.'s Flower Brands Approved for Sale in Virginia Virginia Jushi Holdings...
Global WholeHealth Partners Corp (OTC:GWHP) Now Able to Sell Through Shopify’s Multibillion Dollar Online Platform as Stated in 8k Filing 08/05/21
With 44 million active buyers, Shopify’s online store offers Global WholeHealth Partners Corporation a massive potential. San Clemente, CA, Sept....
